ResearchMoz

Soil Treatment Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018

Transparency Market Research
  Soil treatment processes are used for improving the biological and physical content of the soil which is degrading due to growing industrialization. The pollution caused by industries are mixing in the soil content which makes the soil infertile and further impacts the growth of crops negatively.  
   
 The global volumes demand for soil treatment is expected to grow at a CAGR of over 10% from 2012 to 2018. In terms of revenues, soil treatment market was estimated to be worth over USD 17 billion in 2011 and is expected to exceed a market worth USD 28 billion by 2018, growing at a CAGR of over 8% from 2012 to 2018. The market is primarily driven by growing concerns regarding the depletion of arable land on a global scale, and the government support to improve crop production in...
Table of content is not available for this report as it is upcoming report but you can specify you TOC requirement in our Request sample.

Upcoming Reports:

Contact Lenses Technologies Market- Global And China Forecast, Industry Share, Size, Growth And Industry Analysis (2010-2017)
By - Transparency Market Research
Contact Lenses are medical devices that are worn to improve vision. The major factors driving the contact lenses market are Aesthetics and Cosmetics. The eagerness to change the appearance of their eyes and overall personality is driving the contact lenses market globally. The research report analyses the industry growth rate, industry capacity, supply & demand side and industry structure. The report analyses the historical data and forecasts the contact lenses market size, production forecasts along with key factors driving and restraining the market....
Cystic Fibrosis (CF) Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Cystic fibrosis (CF), also known as mucoviscidosis, is autosomal recessive disorder that is characterized by abnormal transport of chloride and sodium across an epithelium. The occurrence of disease leads to thick and viscous secretions which causes a life threatening impact on the lungs, the pancreas, liver, and intestine, and also blocks the pancreatic enzymatic actions on the body. Cystic fibrosis is caused by mutation in gene, required for protein cystic fibrosis transmembrane conductance regulator (CFTR), a protein required for regulating sweat, mucus and body secretions. The market...
Enterprise Media Gateway Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
A device or service used to translate digital media streams between different types of networks such as 2G, 3G, SS7 and many more. Media gateway is widely used in enterprises to optimize the communication. Some other functions in a media gateway include converting different transmission and coding. Some of the major factors which are boosting up the market of enterprise media gateways include: its growing demand in enterprises where it is used as devices to overcome various challenges faced in multi vendor unified communication environment. The shift in trend of...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:
  • Report will be delivered with in 15-20 working days.

Share this report

Related News

Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...
Export market in New Zealand driven by innovative and high-value food products
Jul 29, 2014  
Demand for beverages and high value foods in Asia are driving the food and beverage industry in New Zealand. Also there is high demand for dairy products, seafood, meat and processed foods in the Asian economies which fuel the give an export boost to the economy of New Zealand.  Asia has a rapidly growing market for food which in turn is highly beneficial for New Zealand’s export...
Sony plans revival of PlayStation with network services
Jul 29, 2014  
After a nearly USD 10 billion loss over the last six years, Sony Corp has plans of reviving its consumer electronics hero – the PlayStation. Sony will be repositioning the video game console as a center of streamed network services such as social media, music and movies apart from games. The matter is still in its infancy stage of discussion and the plan is to generate revenue from the...